Dash Pharmaceuticals

Upper Saddle River, United States Founded: 2014 • Age: 12 yrs Acquired By Natco Pharma
Advanced spectroscopic and laser instrumentation is developed for industrial applications.

About Dash Pharmaceuticals

Dash Pharmaceuticals is a Healthcare company based in Upper Saddle River (United States) founded in 2014 by Julie Trendowicz, David Rosen, and Nick DiMaio, and was acquired by Natco Pharma in December 2021. Advanced spectroscopic and laser instrumentation is developed for industrial applications. Its chief executive, as recorded, is David Rosen. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.

  • Headquarters Upper Saddle River, United States
  • Founders Julie Trendowicz, David Rosen, Nick DiMaio
  • Stage Acquired
  • Sectors
    Healthcare
  • Website dashpharm.com
  • Social LinkedIn
  • Acquired by Natco Pharma (Dec 2021)
Key Metrics

Investors in Dash Pharmaceuticals

Dash Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Natco Pharma.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
APIs and finished dosage forms are developed and manufactured.
1981natcopharma.co.inHyderabad, India
Premium access

Investor details for Dash Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Dash Pharmaceuticals

3 people are tracked at Dash Pharmaceuticals (3 in leadership).

NameRoleGroup
Julie Trendowicz
Co-Founder & VPLeadership
David Rosen
Co-Founder & CEOLeadership
Nick DiMaio
Co-Founder & PresidentLeadership
Premium access

Complete people profiles for Dash Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Dash Pharmaceuticals

2 dated milestones of Dash Pharmaceuticals across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dash Pharmaceuticals is founded.
  2. Exit Acquired by Natco Pharma.

Web traffic of Dash Pharmaceuticals

Websites that share an audience with Dash Pharmaceuticals (dashpharm.com).

Similar websites

Websites whose visitors overlap most with Dash Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.com
100%
85.8B#1View details

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Dash Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dash Pharmaceuticals

Dash Pharmaceuticals was founded in 2014.

Dash Pharmaceuticals is headquartered in Upper Saddle River, United States. It is registered at Upper Saddle River, New Jersey, United States.

David Rosen is the CEO of Dash Pharmaceuticals, as recorded in our data. They have also founded this company.

Developer of advanced spectroscopic and laser-based instrumentation. It designs and manufactures spectrometers and laser systems for various industrial applications, including nuclear decommissioning, high-value manufacturing, pharmaceuticals, and biopharmaceuticals. The companys technology, originally developed for space applications, enables highly sensitive measurement and identification of substances in challenging environments. Its offerings include Raman spectrometers, miniature spectrometers, and bespoke LIDAR solutions. It also provides in-house sampling services and expertise in FabryPérot interferometry. The firm collaborates with industry and academia to develop innovative solutions for complex analytical challenges.

Dash Pharmaceuticals has 1 investor. Key investors include Natco Pharma.

Yes. Dash Pharmaceuticals was acquired by Natco Pharma in December 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available